» Articles » PMID: 28774784

Serum Soluble TREM2 is a Potential Novel Biomarker of Cognitive Impairment in Japanese Non-obese Patients with Diabetes

Overview
Journal Diabetes Metab
Specialty Endocrinology
Date 2017 Aug 5
PMID 28774784
Citations 18
Authors
Affiliations
Soon will be listed here.
Citing Articles

Soluble Triggering Receptors Expressed on Myeloid Cells (sTREM) in Acute Ischemic Stroke: A Potential Pathway of sTREM-1 and sTREM-2 Associated with Disease Severity.

Salafia G, Carandina A, Sacco R, Ferri E, Montano N, Arosio B Int J Mol Sci. 2024; 25(14).

PMID: 39062850 PMC: 11277504. DOI: 10.3390/ijms25147611.


Microglial AKAP8L: a key mediator in diabetes-associated cognitive impairment via autophagy inhibition and neuroinflammation triggering.

Zhang W, Wei Q, Zhang T, Wang C, Chen J, Wang J J Neuroinflammation. 2024; 21(1):177.

PMID: 39033121 PMC: 11264944. DOI: 10.1186/s12974-024-03170-z.


Association between sTREM2, an immune biomarker of microglial activation, and frontal lobe function in community-dwelling older adults: a cross-sectional study.

Orihashi R, Imamura Y, Mizoguchi Y J Rural Med. 2024; 19(3):186-191.

PMID: 38975040 PMC: 11222625. DOI: 10.2185/jrm.2024-018.


Decoding sTREM2: its impact on Alzheimer's disease - a comprehensive review of mechanisms and implications.

Lin C, Kong Y, Chen Q, Zeng J, Pan X, Miao J Front Aging Neurosci. 2024; 16:1420731.

PMID: 38912524 PMC: 11190086. DOI: 10.3389/fnagi.2024.1420731.


Targeting immunometabolic pathways for combination therapy in Alzheimer's disease.

Erichsen J, Craft S Alzheimers Dement (N Y). 2023; 9(4):e12423.

PMID: 37786483 PMC: 10541802. DOI: 10.1002/trc2.12423.